Viewing Study NCT06107322



Ignite Creation Date: 2024-05-06 @ 7:42 PM
Last Modification Date: 2024-10-26 @ 3:12 PM
Study NCT ID: NCT06107322
Status: RECRUITING
Last Update Posted: 2023-10-30
First Post: 2023-10-24

Brief Title: Hematological Effects of Atypical Antipsychotics AAPs in a Geriatric Population What is the Role of 5-HT2 Receptors
Sponsor: University Hospital Strasbourg France
Organization: University Hospital Strasbourg France

Study Overview

Official Title: Retrospective Study on the Hematological Effects of Atypical Antipsychotics AAPs in a Geriatric Population What is the Role of 5-HT2 Receptors
Status: RECRUITING
Status Verified Date: 2023-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: AAPs
Brief Summary: White lineage abnormalities and in particular neutropenia and agranulocytosis are known and increasingly studied adverse effects of antipsychotics particularly second generation White lineage abnormalities have been found with each of the drugs in this class even if progression to agranulocytosis is rarer with drugs other than Clozapine

The infections sometimes serious induced by these adverse effects have largely led to limiting the use of second generation antipsychotics and in particular clozapine to the treatment of patients resistant to other first or second line treatments

Several hypotheses have been put forward the first is that of an immuno-allergic reaction mediated by eosinophils with increased sensitivity depending on the HLA type another that of a direct toxic effect of clozapine or its main metabolite N -demethylclozapine and a third attributes hematological disorders to catecholaminergic inhibition which prevents the differentiation of CD34 hematopoietic stem cells into leukocytes after blocking dopaminergic andor beta-adrenergic receptors

More recently a new hypothesis is emerging following scandals particularly in France linked to Benfluorex Mediator Dexfenfluramine Isomeride and Fenfluramine Pondéral Indeed by studying the cellular mechanisms linked to the stimulation of the 5-HT2B receptor by their common metabolite Nordexfenfluramine researchers from the NeuroCardiovascular pharmacology and toxicology laboratory in Strasbourg have demonstrated that the stimulation of 5-HT2BR mobilizes CD34 cells in blood from the bone marrow and selective blocking of 5-HT2B receptors reduces the number of leukocytes in the blood mainly neutrophils and lymphocytes further decreasing their blood concentration with exposure time
Detailed Description: The investigators chose as their study population an elderly to very elderly population hospitalized or residing in the Geriatrics center of a university hospital Indeed apart from resistant schizophrenia clozapine is the reference antipsychotic in behavioral disorders associated with the dementia of Parkinsons disease Lewy body disease and other atypical parkinsonian syndromes particularly because of its antagonism dopaminergic less important The absence of equivalent therapy justifies studying the occurrence of adverse effects precisely in this population Studies have already taken place on clozapine in this indication but to our knowledge none have sought to demonstrate the occurrence of white lineage disorders based on its effects on 5-HT2 receptors

This study could provide a better understanding of the role and function of serotonin receptors of the 5-HT2 subtype on the differentiationmobilization of hematopoietic cells with the clinical challenge of better prescription in the geriatric population often fragile of atypical neuroleptics which are the only therapeutic alternative in the delusional disorders of patients with Lewy bodies but also used in other neurodegenerative disorders

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None